Use of inhaled corticosteroids and the risk of fracture


Hubbard, R; Tattersfield, A; Smith, C; West, J; Smeeth, L; Fletcher, A; (2006) Use of inhaled corticosteroids and the risk of fracture. Chest, 130 (4). pp. 1082-1088. ISSN 0012-3692 DOI: https://doi.org/10.1378/chest.130.4.1082

Full text not available from this repository. (Request a copy)

Abstract

Background: Previous studies have found an association between the use of inhaled corticosteroids and fracture, but the extent to which this association is due to inhaled corticosteroids or to related factors, such as the severity of airflow obstruction, is disputed. We report a new approach in which we combine data on people with airflow obstruction from a large Medical Research Council study of the assessment and management of older people in the community with longitudinal data from their computerized general practice records. Methods: Our cohort includes 1,671 study participants with a diagnosis of asthma or COPD (mean age, 80.6 years). We determined the dose-response relationship between inhaled corticosteroid exposure and time to first fracture using Cox regression, allowing for a wide range of potential confounding factors. Results: During a mean follow-up period of 9.4 years, 982 patients (59%) received a prescription for an inhaled corticosteroid and 187 patients had a fracture. After adjusting for the effects of age and gender, we found a dose-related increase in fracture risk with exposure to inhaled corticosteroids (rate ratio for mean daily dose > 601 mu g, 2.53; 95% confidence interval [CI], 1.65 to 3.89; overall trend p < 0.0001). The results were similar after adjusting for oral corticosteroid exposure, airflow. obstruction diagnosis, historical fracture, and bronchodilator use (rate ratio, 4.21; 95% CI, 2.19 to 8.13), and also in the subset of people with no exposure to oral corticosteroids (rate ratio, 4.54; 95% CI, 1.23 to 16.74). Conclusions: Our findings provide further evidence that inhaled corticosteroid use is an independent risk factor for fracture.

Item Type: Article
Keywords: bone mineral density, cohort study, fracture, inhaled corticosteroids, OBSTRUCTIVE PULMONARY-DISEASE, BONE-MINERAL DENSITY, OLDER-PEOPLE, MRC, TRIAL, BUDESONIDE, FLUTICASONE, MANAGEMENT, COMMUNITY, ASTHMA, UK, Administration, Inhalation, Adrenal Cortex Hormones, administration & dosage, adverse effects, Aged, Aged, 80 and over, Asthma, drug therapy, epidemiology, physiopathology, Cohort Studies, Confidence Intervals, Dose-Response Relationship, Drug, Family Practice, Female, Follow-Up Studies, Fractures, Spontaneous, chemically induced, epidemiology, physiopathology, Geriatric Assessment, Great Britain, Humans, Male, Pulmonary Disease, Chronic Obstructive, drug therapy, epidemiology, physiopathology, Regression Analysis, Risk Factors, Statistics
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
Research Centre: Centre for Global Non-Communicable Diseases (NCDs)
PubMed ID: 17035441
Web of Science ID: 241265700025
URI: http://researchonline.lshtm.ac.uk/id/eprint/10528

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
329Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item